Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)
Owlet (OWLT) reported Net Income towards Common Stockholders of -$4.1 million for Q1 2026, down 336.96% year-over-year from $1.7 million in Q1 2025, and up 58.15% on a QoQ basis from -$9.9 million in Q4 2025.
Owlet (OWLT) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$4.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 336.96% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.6 million (down 179.48% YoY) and the FY2025 annual result came in at -$41.9 million, down 143.1% from the prior year.
- Net Income towards Common Stockholders improved to -$4.1 million in Q1 2026 per OWLT's latest filing, from -$9.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.7 million in Q3 2025 and bottomed at -$37.2 million in Q2 2025.
- The 5-year median for Net Income towards Common Stockholders is -$9.7 million (2024), against an average of -$10.7 million.
- Peak annual rise in Net Income towards Common Stockholders reached 139.61% in 2025, while the deepest fall reached 1286.54% in 2025.
- Tracing OWLT's Net Income towards Common Stockholders over 5 years: stood at -$19.5 million in 2022, then surged by 57.85% to -$8.2 million in 2023, then fell by 17.8% to -$9.7 million in 2024, then dropped by 2.23% to -$9.9 million in 2025, then jumped by 58.15% to -$4.1 million in 2026.
- Per Business Quant, the three latest OWLT Net Income towards Common Stockholders figures stand at -$4.1 million (Q1 2026), -$9.9 million (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Owlet | 150.10 Mn | 109.09 Mn | 12.24 Mn | -4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -9.90 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -37.19 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -6.76 Mn |
| Jun 30, 2024 | -2.68 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | -8.22 Mn |
| Sep 30, 2023 | -6.96 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -12.52 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -5.34 Mn |
| Mar 31, 2021 | -7.86 Mn |
| Dec 31, 2020 | -8.25 Mn |
| Sep 30, 2020 | -1.50 Mn |
| Jun 30, 2020 | -1,000.00 |